Journal of General Virology, Vol 79, 83-90, Copyright © 1998 by Society for General Microbiology

ARTICLES

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice

T Hanke, TJ Blanchard, J Schneider, GS Ogg, R Tan, M Becker, SC Gilbert, AV Hill, GL Smith and A McMichael
Molecular Immunology Group, Institute of Molecular Medicine, University of Oxford, The John Radcliffe, UK. hanke@ermine.ox.ac.uk

A vaccine against human immunodeficiency virus (HIV) is still awaited. Although the correlates of protection remain elusive, it is likely that CD8+ T cells play an important role in the control of this infection. To firmly establish the importance of these cells in protective immunity, a means of efficient elicitation of CD8+ T cell responses in the absence of antibody is needed and, when available, might represent a crucial step towards a protective vaccine. Here, a novel vaccine candidate was constructed as a multi-cytotoxic T lymphocyte (CTL) epitope gene delivered and expressed using modified vaccinia virus Ankara (MVA). The immunogen consists of 20 human, one murine and three rhesus macaque epitopes. The non-human epitopes were included so that the vaccine can be tested for immunogenicity and optimal vaccination doses, routes and regimes in experimental animals. Mice were immunized intravenously (i.v.) or intramuscularly (i.m.) using a single dose of 10(6) p.f.u. of the recombinant MVA and the induction of CTL was assessed. It was demonstrated that both administration routes induced specific CTL responses and that the i.v. route was moderately more immunogenic than the i.m. route. The frequencies of ex vivo splenocytes producing interferon-y upon MHC class I-restricted peptide stimulation were determined using an ELISPOT assay. Also, the correct processing and presentation of some HLA-restricted epitopes in human cells was confirmed.

This article has been cited by other articles:

				J. W. Hodge, D. J. Poole, W. M. Aarts, A. Gomez Yafal, L. Gritz, and J. Schlom Modified Vaccinia Virus Ankara Recombinants Are as Potent as Vaccinia Recombinants in Diversified Prime and Boost Vaccine Regimens to Elicit Therapeutic Antitumor Responses Cancer Res., November 15, 2003; 63(22): 7942 - 7949. [Abstract] [Full Text] [PDF]

				G. Gonzalez-Aseguinolaza, Y. Nakaya, A. Molano, E. Dy, M. Esteban, D. Rodriguez, J. R. Rodriguez, P. Palese, A. Garcia-Sastre, and R. S. Nussenzweig Induction of Protective Immunity against Malaria by Priming-Boosting Immunization with Recombinant Cold-Adapted Influenza and Modified Vaccinia Ankara Viruses Expressing a CD8+-T-Cell Epitope Derived from the Circumsporozoite Protein of Plasmodium yoelii J. Virol., November 1, 2003; 77(21): 11859 - 11866. [Abstract] [Full Text] [PDF]

				X. Shen, S. B. J. Wong, C. B. Buck, J. Zhang, and R. F. Siliciano Direct Priming and Cross-Priming Contribute Differentially to the Induction of CD8+ CTL Following Exposure to Vaccinia Virus Via Different Routes J. Immunol., October 15, 2002; 169(8): 4222 - 4229. [Abstract] [Full Text] [PDF]

				T. M. Allen, P. Jing, B. Calore, H. Horton, D. H. O'Connor, T. Hanke, M. Piekarczyk, R. Ruddersdorf, B. R. Mothe, C. Emerson, et al. Effects of Cytotoxic T Lymphocytes (CTL) Directed against a Single Simian Immunodeficiency Virus (SIV) Gag CTL Epitope on the Course of SIVmac239 Infection J. Virol., September 11, 2002; 76(20): 10507 - 10511. [Abstract] [Full Text] [PDF]

				P. K. Hocknell, R. D. Wiley, X. Wang, T. G. Evans, W. J. Bowers, T. Hanke, H. J. Federoff, and S. Dewhurst Expression of Human Immunodeficiency Virus Type 1 gp120 from Herpes Simplex Virus Type 1-Derived Amplicons Results in Potent, Specific, and Durable Cellular and Humoral Immune Responses J. Virol., May 3, 2002; 76(11): 5565 - 5580. [Abstract] [Full Text] [PDF]

				P. Potter, S. Tourdot, T. Blanchard, G. L. Smith, and K. G. Gould Differential processing and presentation of the H-2Db-restricted epitope from two different strains of influenza virus nucleoprotein J. Gen. Virol., May 1, 2001; 82(5): 1069 - 1074. [Abstract] [Full Text]

				M. M. Gherardi, J. C. Ramírez, and M. Esteban Interleukin-12 (IL-12) Enhancement of the Cellular Immune Response against Human Immunodeficiency Virus Type 1 Env Antigen in a DNA Prime/Vaccinia Virus Boost Vaccine Regimen Is Time and Dose Dependent: Suppressive Effects of IL-12 Boost Are Mediated by Nitric Oxide J. Virol., July 15, 2000; 74(14): 6278 - 6286. [Abstract] [Full Text]

				T. M. Allen, T. U. Vogel, D. H. Fuller, B. R. Mothe, S. Steffen, J. E. Boyson, T. Shipley, J. Fuller, T. Hanke, A. Sette, et al. Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen J. Immunol., May 1, 2000; 164(9): 4968 - 4978. [Abstract] [Full Text] [PDF]

				A. Seth, I. Ourmanov, J. E. Schmitz, M. J. Kuroda, M. A. Lifton, C. E. Nickerson, L. Wyatt, M. Carroll, B. Moss, D. Venzon, et al. Immunization with a Modified Vaccinia Virus Expressing Simian Immunodeficiency Virus (SIV) Gag-Pol Primes for an Anamnestic Gag-Specific Cytotoxic T-Lymphocyte Response and Is Associated with Reduction of Viremia after SIV Challenge J. Virol., March 15, 2000; 74(6): 2502 - 2509. [Abstract] [Full Text]

				I. Ourmanov, C. R. Brown, B. Moss, M. Carroll, L. Wyatt, L. Pletneva, S. Goldstein, D. Venzon, and V. M. Hirsch Comparative Efficacy of Recombinant Modified Vaccinia Virus Ankara Expressing Simian Immunodeficiency Virus (SIV) Gag-Pol and/or Env in Macaques Challenged with Pathogenic SIV J. Virol., March 15, 2000; 74(6): 2740 - 2751. [Abstract] [Full Text]

				J. C. Ramírez, M. M. Gherardi, and M. Esteban Biology of Attenuated Modified Vaccinia Virus Ankara Recombinant Vector in Mice: Virus Fate and Activation of B- and T-Cell Immune Responses in Comparison with the Western Reserve Strain and Advantages as a Vaccine J. Virol., January 1, 2000; 74(2): 923 - 933. [Abstract] [Full Text]

				T. Hanke, R. V. Samuel, T. J. Blanchard, V. C. Neumann, T. M. Allen, J. E. Boyson, S. A. Sharpe, N. Cook, G. L. Smith, D. I. Watkins, et al. Effective Induction of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Macaques by Using a Multiepitope Gene and DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccination Regimen J. Virol., September 1, 1999; 73(9): 7524 - 7532. [Abstract] [Full Text]

				E. Desmézières, Y. Jacob, M.-F. Saron, F. Delpeyroux, N. Tordo, and P. Perrin Lyssavirus glycoproteins expressing immunologically potent foreign B cell and cytotoxic T lymphocyte epitopes as prototypes for multivalent vaccines J. Gen. Virol., September 1, 1999; 80(9): 2343 - 2351. [Abstract] [Full Text]

				T. Woodberry, J. Gardner, L. Mateo, D. Eisen, J. Medveczky, I. A. Ramshaw, S. A. Thomson, R. A. Ffrench, S. L. Elliott, H. Firat, et al. Immunogenicity of a Human Immunodeficiency Virus (HIV) Polytope Vaccine Containing Multiple HLA A2 HIV CD8+ Cytotoxic T-Cell Epitopes J. Virol., July 1, 1999; 73(7): 5320 - 5325. [Abstract] [Full Text]

				I. M. Belyakov, B. Moss, W. Strober, and J. A. Berzofsky Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity PNAS, April 13, 1999; 96(8): 4512 - 4517. [Abstract] [Full Text] [PDF]

				D. M. Mwaengo and F. J. Novembre Molecular Cloning and Characterization of Viruses Isolated from Chimpanzees with Pathogenic Human Immunodeficiency Virus Type 1 Infections J. Virol., November 1, 1998; 72(11): 8976 - 8987. [Abstract] [Full Text] [PDF]

				I. M. Belyakov, L. S. Wyatt, J. D. Ahlers, P. Earl, C. D. Pendleton, B. L. Kelsall, W. Strober, B. Moss, and J. A. Berzofsky Induction of a Mucosal Cytotoxic T-Lymphocyte Response by Intrarectal Immunization with a Replication-Deficient Recombinant Vaccinia Virus Expressing Human Immunodeficiency Virus 89.6 Envelope Protein J. Virol., October 1, 1998; 72(10): 8264 - 8272. [Abstract] [Full Text] [PDF]

				A. Seth, I. Ourmanov, M. J. Kuroda, J. E. Schmitz, M. W. Carroll, L. S. Wyatt, B. Moss, M. A. Forman, V. M. Hirsch, and N. L. Letvin Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer PNAS, August 18, 1998; 95(17): 10112 - 10116. [Abstract] [Full Text] [PDF]